These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 27264503)

  • 1. Corrigendum to "abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].
    Alvarado-Alanis P; León-Ortiz P; Reyes-Madrigal F; Favila R; Rodríguez-Mayoral O; Nicolini H; Azcárraga M; Graff-Guerrero A; Rowland LM; de la Fuente-Sandoval C
    Schizophr Res; 2016 Oct; 176(2-3):582. PubMed ID: 27264503
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis.
    Alvarado-Alanis P; León-Ortiz P; Reyes-Madrigal F; Favila R; Rodríguez-Mayoral O; Nicolini H; Azcárraga M; Graff-Guerrero A; Rowland LM; de la Fuente-Sandoval C
    Schizophr Res; 2015 Mar; 162(1-3):14-21. PubMed ID: 25620120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.
    Zeng B; Ardekani BA; Tang Y; Zhang T; Zhao S; Cui H; Fan X; Zhuo K; Li C; Xu Y; Goff DC; Wang J
    Schizophr Res; 2016 Apr; 172(1-3):1-8. PubMed ID: 26852402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "Therapeutic Effectiveness and Tolerability of Aripiprazole as Initial Choice of Treatment in First Episode Psychosis in an Early Intervention Service: A One-Year Outcome Study" [Schizophr. Res. 147, 120-125].
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2018 Mar; 193():490. PubMed ID: 29550056
    [No Abstract]   [Full Text] [Related]  

  • 5. Extensive white matter abnormalities and clinical symptoms in drug-naive patients with first-episode schizophrenia: a voxel-based diffusion tensor imaging study.
    Zhang XY; Fan FM; Chen DC; Tan YL; Tan SP; Hu K; Salas R; Kosten TR; Zunta-Soares G; Soares JC
    J Clin Psychiatry; 2016 Feb; 77(2):205-11. PubMed ID: 26761708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corrigendum to "Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study" [Schizophr. Res. volume 225 (May 2023) 173-181].
    Millgate E; Smart SE; Pardiñas AF; Kravariti E; Ajnakina O; Kępińska AP; Andreassen OA; Barnes TRE; Berardi D; Crespo-Facorro B; D'Andrea G; Demjaha A; Di Forti M; Doody GA; Üçok A; Kassoumeri L; Ferchiou A; Guidi L; Joyce EM; Lastrina O; Melle I; Pignon B; Richard JR; Simonsen C; Szöke A; Tarricone I; Tortelli A; Vázquez-Bourgon J; Murray RM; Walters JTR; MacCabe JH;
    Schizophr Res; 2024 Aug; 270():495-496. PubMed ID: 39079354
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment [Schizophr. Res. 168 (2015) 587-588].
    van de Bilt MT; Prado CM; Ojopi EPB; de Sousa RT; Loch AA; Zanetti MV; Talib LL; Gattaz WF
    Schizophr Res; 2016 Jul; 174(1-3):204. PubMed ID: 27066861
    [No Abstract]   [Full Text] [Related]  

  • 8. Abnormal resting state FMRI activity predicts processing speed deficits in first-episode psychosis.
    Argyelan M; Gallego JA; Robinson DG; Ikuta T; Sarpal D; John M; Kingsley PB; Kane J; Malhotra AK; Szeszko PR
    Neuropsychopharmacology; 2015 Jun; 40(7):1631-9. PubMed ID: 25567423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion tensor imaging in the early phase of schizophrenia: what have we learned?
    Peters BD; Blaas J; de Haan L
    J Psychiatr Res; 2010 Nov; 44(15):993-1004. PubMed ID: 20554292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter fibertracking in first-episode schizophrenia, schizoaffective patients and subjects at ultra-high risk of psychosis.
    Peters BD; de Haan L; Dekker N; Blaas J; Becker HE; Dingemans PM; Akkerman EM; Majoie CB; van Amelsvoort T; den Heeten GJ; Linszen DH
    Neuropsychobiology; 2008; 58(1):19-28. PubMed ID: 18781087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "Neuroanatomical correlates of perceptual aberrations in psychosis" [Schizophr. Res. 179 (2017) 125-131].
    Brosey EA; Woodward ND
    Schizophr Res; 2018 Jul; 197():624. PubMed ID: 29699896
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado" [Schizophr. Res. 157 (0) (August 2014) 317-318].
    Carol EE; Mittal VA
    Schizophr Res; 2018 Feb; 192():494. PubMed ID: 28476338
    [No Abstract]   [Full Text] [Related]  

  • 13. Fronto-temporal disconnectivity and clinical short-term outcome in first episode psychosis: a DTI-tractography study.
    Luck D; Buchy L; Czechowska Y; Bodnar M; Pike GB; Campbell JS; Achim A; Malla A; Joober R; Lepage M
    J Psychiatr Res; 2011 Mar; 45(3):369-77. PubMed ID: 20708198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corrigendum to "resilience in schizophrenia: A comparative study between a remote island and an urban area in Japan" [Schizophr. Res. Volume 171, Issues 1-3, March 2016, Pages 92-96].
    Yoshida K; Suzuki T; Imasaka Y; Kubo KI; Mizuno Y; Saruta J; Tsukinoki K; Mimura M; Uchida H
    Schizophr Res; 2016 Oct; 176(2-3):580. PubMed ID: 27539074
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic use in a first episode psychosis program.
    Manchanda R; Norman RM; Malla AK; Manocha R
    Int J Psychiatry Clin Pract; 2007; 11(2):151-6. PubMed ID: 24937561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Increased diffusivity in gray matter in recent onset schizophrenia is associated with clinical symptoms and social cognition" [Schizophr. Res. 176 (2-3) (Oct 2016) 144-150].
    Lee JS; Kim CY; Joo YH; Newell D; Bouix S; Shenton ME; Kubicki M
    Schizophr Res; 2017 Mar; 181():137. PubMed ID: 27890401
    [No Abstract]   [Full Text] [Related]  

  • 17. White matter tract abnormalities in first-episode psychosis.
    Lee DY; Smith GN; Su W; Honer WG; Macewan GW; Lapointe JS; Vertinsky AT; Vila-Rodriguez F; Kopala LC; Lang DJ
    Schizophr Res; 2012 Oct; 141(1):29-34. PubMed ID: 22863549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter alterations in first episode treatment-naïve patients with deficit schizophrenia: a combined VBM and DTI study.
    Lei W; Li N; Deng W; Li M; Huang C; Ma X; Wang Q; Guo W; Li Y; Jiang L; Zhou Y; Hu X; McAlonan GM; Li T
    Sci Rep; 2015 Aug; 5():12994. PubMed ID: 26257373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analyses of thalamic volume, shape and white matter integrity in first-episode schizophrenia.
    Qiu A; Zhong J; Graham S; Chia MY; Sim K
    Neuroimage; 2009 Oct; 47(4):1163-71. PubMed ID: 19375511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White matter defects in first episode psychosis patients: a voxelwise analysis of diffusion tensor imaging.
    Pérez-Iglesias R; Tordesillas-Gutiérrez D; Barker GJ; McGuire PK; Roiz-Santiañez R; Mata I; de Lucas EM; Quintana F; Vazquez-Barquero JL; Crespo-Facorro B
    Neuroimage; 2010 Jan; 49(1):199-204. PubMed ID: 19619664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.